Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - yellox
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp802da6d86549eecc6e51c1bae9cf0471
identifier: http://ema.europa.eu/identifier
/EU/1/11/692/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Yellox 0.9 mg/ml eye drops solution
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-802da6d86549eecc6e51c1bae9cf0471
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/11/692/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - yellox
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet:
Yellox contains bromfenac and belongs to a group of medicines called non-steroidal anti- inflammatory drugs (NSAIDs). It works by blocking certain substances involved in causing inflammation.
Yellox is used to reduce eye inflammation following cataract surgery in adults.
Do not use Yellox
Warning and precautions
Talk to your doctor or pharmacist before using this medicine
Wearing contact lenses is not recommended after cataract surgery. Therefore, do not wear contact lenses whilst using Yellox.
Children and adolescents Yellox should not be used in children and adolescents.
Other medicines and Yellox
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Pregnancy, breastfeeding and fertility If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask
your doctor for advice before you use Yellox. Yellox should not be used during the last three months of pregnancy. The doctor may prescribe this medicine during pregnancy if expected benefit to mother outweigh possible risk to baby.
Yellox may be prescribed to breast-feeding woman and have no important influence on fertility.
Driving and using machines Your vision may be blurred for a short time after using this eye drops. If you experience blurred vision upon instillation, do not drive or use machines until your vision is clear.
Yellox contains benzalkonium chloride This medicine contains 0.00185 mg benzalkonium chloride in each drop which is equivalent to 0.05 mg/ml.
Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back minutes afterwards.
Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Dose
The recommended dose is one drop of Yellox in the affected eye(s) twice daily (morning and evening). Do not use more than one drop in the affected eye(s) 2 times daily. Start using the drops the next day after your cataract surgery.
Method of administration
Yellox is for ocular use.
If you use any other eye drops, wait at least five minutes between using Yellox and the other drops.
Duration of treatment Continue the drops through the first 2 weeks after your surgery. Do not use Yellox longer than 2weeks.
If you use more Yellox than you should Rinse out your eye with warm water. Do not put in any more drops until it is time for your next regular dose. If Yellox is accidentally swallowed, a glass of water or other fluid should be taken to water down the medicine.
If you forget to use Yellox
Use a single dose as soon as you remember. If it is almost time for the next dose, leave out the missed dose. Continue with the next regularly scheduled dose. Do not use a double dose to make up for a forgotten dose.
If you stop using Yellox
Do not stop using Yellox without speaking to your doctor.
In rare cases upon withdrawal of Yellox, a flare-up of the inflammatory response, e.g. in the form of retina swelling, due to the cataract operation has been observed.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience decreased or blurred vision the week after the end of treatment, contact your doctor immediately. If you notice any of the following side effects while using the drops, contact your doctor immediately:
Uncommon side effects (may affect up to 1 in 100 people) Foreign body sensation in the eye, redness and inflammation of the eye, damage and inflammation of the surface of the eye, eye discharge, itching, irritation or pain of the eye, swelling or bleeding of the eyelid, impaired vision due to inflammation, floaters or moving spots before the eyes or diminishing vision that can indicate bleeding or damage of the back of the eye (retina), ocular discomfort, sensitivity to light, reduced or blurred vision, swelling of the face, cough, nosebleeding or runny nose.
Rare side effects (may affect up to 1 in 1,000 people)
Damage of the eye surface, redness of the eye, asthma.
Reporting of side effects If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle and outer carton after EXP . The expiry date refers to the last day of that month.
Do not store above 25 C.
Discard the bottle 4 weeks after first opening to prevent infection even if there is solution remaining. Write the date of opening on the carton label in the space provided.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away of medicines you no longer use. These measures will help to protect the environment.
What Yellox contains
What Yellox looks like and contents of the pack Yellox is a clear yellow liquid (solution) supplied in a pack containing one 5 ml plastic bottle with a screw cap.
Marketing Authorisation Holder
BAUSCH + LOMB IRELAND LIMITED 3013 Lake Drive Citywest Business Campus Dublin 24, D24PPT3 Ireland
Manufacturer Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH Brunsb tteler Damm 165/13581 Berlin Germany
This leaflet was last revised in
Detailed information on this medicine is available on the website of the European Medicines Agency
Entry 1 - fullUrl = Composition/composition-en-802da6d86549eecc6e51c1bae9cf0471
Resource Composition:
Generated Narrative: Composition composition-en-802da6d86549eecc6e51c1bae9cf0471
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/11/692/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - yellox
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp802da6d86549eecc6e51c1bae9cf0471
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp802da6d86549eecc6e51c1bae9cf0471
identifier:
http://ema.europa.eu/identifier
/EU/1/11/692/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Yellox 0.9 mg/ml eye drops solution
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en